Spirit Digital

Spirit Digital

Spirit Digital’s CliniTouch Vie platform uses remote monitoring to help patients self-manage conditions and enable healthcare teams to proactively monitor patients safely at their home or usual place of residence, enabling prioritised focus on those who need support. The platform supports pathways and conditions including Chronic Obstructive Pulmonary Disease (COPD), heart failure services, frailty patients and care home healthcare, and early discharge and post surgery services. The platform has been particularly relevant during the Covid-19 pandemic as COPD patients are in the high risk category.

Find your nearest AHSN

Coordinates
By Spirit Digital

Overview

It is estimated that 3 million people in the UK are living with COPD. This makes it the second most common lung disease in the UK following asthma. The estimated annual cost of COPD to the NHS is £1.9 billion.

In 2016, Spirit’s CliniTouch Vie was part of a research study using admissions data from University Hospitals of Leicester NHS Trust. Data was analysed relating to the impact on COPD-related admissions and overall resource use – comparing a 12 month period with and without patients using the CliniTouch Vie COPD self-management platform.

The study showed that over a 12 month period through using CliniTouch Vie:

  • 148 unplanned emergency COPD admissions were prevented
  • Reduced admissions savings of £117k over 12 months (on a mean number of patients enrolled of 54)
  • Reduction in home visits (provider efficiencies)
  • Patient improvements in self-management, education and confidence

Admissions per head reduced from 3.13 to 1.02 per year.

How did the Innovation Exchange help?

East Midlands AHSN started working with Spirit in 2018 as part of the East Midlands Digital Health Accelerator. The support focused on the CliniTouch Vie platform and use for COPD patients. Through the Digital Health Accelerator, which offers tailored support to Digital Health innovators, Spirit received guidance on :

  • Developing their messaging and proposition
  • Coaching and mentoring
  • Group development sessions with other companies
  • Funding applications

As well as receiving in-depth guidance and access to expertise, Spirit have also benefited from exposure to healthcare professionals and stakeholders at high profile and targeted events. They have also recently won a Medilink East Midlands Award for Delivering Innovation in Health and Care, which was sponsored by East Midlands AHSN. All of these opportunities have provided Spirit with exposure and a platform to highlight their product – which they would not have had easy access to without the AHSN.

Since joining the East Midlands Digital Health Accelerator in 2018, Spirit Digital have seen steady growth. They have also received a European Space Agency (ESA) Business Applications and Space Solutions award and a six-figure match funded grant to incorporate real-time air quality data into the platform, which will add a new dimension for patients to self-manage even more effectively.

Impact & Outcomes

CliniTouch Vie has seen tens of thousands of patient interactions take place on its platform and in 2018-19 secured a large contract roll over and new contract commencement with NHS organisations. With several contract proposals currently on-going with NHS Trusts up and down the country, CliniTouch Vie will benefit more patients and will be introduced to more clinical pathways through 2020 and beyond.

Spirit are working on a demonstrator project focusing on research on air quality data and the impact on those living with COPD as a result of their recent European Space Agency grant. Following this research, they will incorporate additional functionality within their Clinitouch Vie platform to help people gain a better understanding of when their symptoms may be exacerbated because of changes in air quality. These developments aim to make their product more versatile and widen its potential impact and appeal.

They will continue to work with the East Midlands AHSN on their plans for further stakeholder engagement and increase visibility of their product to the NHS market.